ACTRN12611000880943招募中2 期
A randomised, open-label, multicentre trial to determine safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in living donor kidney transplant recipients requiring desensitization therapy
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Male or female patients >=18 years old
- •2.Patients with Stage IV or Stage V chronic kidney disease who will receive a kidney transplant from a living donor to whom they are sensitized and require desensitization prior to transplantation
- •3.Able to understand the informed consent form and willing to comply with study procedures
排除标准
- •1.Hypersensitivity to eculizumab, to murine proteins or to one of the excipients
- •2.Any medical condition that, in the opinion of the Investigator, might interfere with the patient's participation in the study, poses an added risk for the patient, or confounds the assessment of the patient
研究者
相似试验
进行中（未招募）
不适用
A randomised, open-label, multi-centre trial investigating the intra-subject variability of ROTEM® and TEG® parameters following two intravenous administrations of the same dose of activated recombinant factor VII (rFVIIa/NovoSeven®) in haemophilia patients in a non-bleeding stateHaemophiliaMedDRA version: 7.1Level: LLTClassification code 10061992EUCTR2005-000891-42-DKovo Nordisk A/S30
招募中
不适用
se of triple combination for falciparum malariaCTRI/2017/09/009594K Department for International Development DFID
进行中（未招募）
不适用
A randomized, open label, multicentre trial to define the most effective haemoglobin concentration to start erythropoietin beta (neoRecormon) therapy in anaemic subjects with lymphoproliferative malignancy receivin chemotherapyREPOSstudy - Repos studyAnemia in cancer patientsEUCTR2006-003727-37-NLHaga Teaching Hospital150
已完成
3 期
A randomized, open label, multicentre trial to define the most effective haemoglobin concentration to start erythropoietin beta (neoRecormon) therapy in anaemic subjects with lymphoproliferative malignancy receiving chemotherapy *REPOS Study*anemiaNL-OMON34234HagaZiekenhuis150
进行中（未招募）
1 期
trial comparing different doses of single-dose tocilizumab in adults with severe COVID-19 infectioCOVID-19 infectionMedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001767-86-IEniversity College Dublin90